STERLING PHARMA SOLUTIONS LIMITED

Active Cramlington

Manufacture of basic pharmaceutical products

644 employees website.com
Life sciences and medical technology Manufacture of basic pharmaceutical products
S

STERLING PHARMA SOLUTIONS LIMITED

Manufacture of basic pharmaceutical products

Founded 16 Feb 2006 Active Cramlington, United Kingdom 644 employees website.com
Life sciences and medical technology Manufacture of basic pharmaceutical products

Previous Company Names

SHASUN PHARMA SOLUTIONS LIMITED 16 Feb 2006 — 14 Sept 2016
Accounts Submitted 18 Dec 2025 Next due 31 Dec 2026 7 months remaining
Confirmation Submitted 28 Jan 2026 Next due 11 Feb 2027 9 months remaining
Net assets £-27M £79M 2024 year on year
Total assets £259M £101M 2024 year on year
Total Liabilities £287M £23M 2024 year on year
Charges 22
3 outstanding 19 satisfied

Contact & Details

Contact

Registered Address

Dudley Lane Dudley Cramlington NE23 7QG United Kingdom

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for STERLING PHARMA SOLUTIONS LIMITED (05712796), an active life sciences and medical technology company based in Cramlington, United Kingdom. Incorporated 16 Feb 2006. Manufacture of basic pharmaceutical products. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Balance Sheet & P&L (2013–2024)

Cash in Bank

£15.25M

Increased by £7.21M (+90%)

Net Assets

-£27.11M

Decreased by £78.90M (-152%)

Total Liabilities

£286.50M

Decreased by £22.54M (-7%)

Turnover

£78.07M

Decreased by £37.40M (-32%)

Employees

644

Decreased by 10 (-2%)

Debt Ratio

110%

Increased by 24 (+28%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Grants 3

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

3 Allotments 229,005 Shares £300k Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
26 Jan 201876,335£100k£1.31
26 Jan 201876,335£100k£1.31
30 Nov 201776,335£100k£1.31

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (1)

Saffron Bidco Limited
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active 2 Ceased

Saffron Bidco Limited

United Kingdom

Active
Notified 27 Feb 2019
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Arun Kumar Pillai

Ceased 27 Feb 2019

Ceased

Saffron Bidco Limited

Ceased 27 Feb 2019

Ceased

Group Structure

Group Structure

VANQUISH BIDCO LIMITED united kingdom
SAFFRON BIDCO LIMITED united kingdom
STERLING PHARMA SOLUTIONS LIMITED Current Company

Charges

Charges

3 outstanding 19 satisfied

Properties

Properties

1 freehold 1 total
AddressTenurePrice PaidDate Added
land and buildings lying to the west of Northern Terrace, Dudley NORTH TYNESIDE
Freehold-24 Apr 2006
land and buildings lying to the west of Northern Terrace, Dudley
Freehold
Added 24 Apr 2006
District NORTH TYNESIDE

Documents

Company Filings

DateCategoryDescriptionDocument
2 Apr 2026CapitalAllotment of shares (GBP 27,469,547) on 31 Mar 2026
28 Jan 2026Confirmation StatementConfirmation statement made on 28 Jan 2026 with no updates
18 Dec 2025AccountsAnnual accounts made up to 31 Mar 2025
12 Nov 2025OfficersAppointment of Mr Karl Rotthier as director on 3 Nov 2025
12 Nov 2025OfficersTermination of Kevin Peter Cook as director on 31 Oct 2025
2 Apr 2026 Capital

Allotment of shares (GBP 27,469,547) on 31 Mar 2026

28 Jan 2026 Confirmation Statement

Confirmation statement made on 28 Jan 2026 with no updates

18 Dec 2025 Accounts

Annual accounts made up to 31 Mar 2025

12 Nov 2025 Officers

Appointment of Mr Karl Rotthier as director on 3 Nov 2025

12 Nov 2025 Officers

Termination of Kevin Peter Cook as director on 31 Oct 2025

Recent Activity

Latest Activity

Allotment of shares (GBP 27,469,547) on 31 Mar 2026

1 months ago on 2 Apr 2026

Confirmation statement made on 28 Jan 2026 with no updates

3 months ago on 28 Jan 2026

Annual accounts made up to 31 Mar 2025

4 months ago on 18 Dec 2025

Appointment of Mr Karl Rotthier as director on 3 Nov 2025

6 months ago on 12 Nov 2025

Termination of Kevin Peter Cook as director on 31 Oct 2025

6 months ago on 12 Nov 2025